title: Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonists.
abstract: A series of cyclic pseudopeptides of the formula cyclo(Leu psi[CH2NH]Xaa-Gln-Trp-Phe-beta Ala), where Xaa represents the residue of an alpha-amino acid, has been synthesized in order to establish the role of the Xaa side chain for tachykinin NK-2 receptor antagonist activity. Syntheses have been carried out in solid phase with either Fmoc or Boc strategy. The antagonist potency on NK-2 receptors in the hamster isolated trachea (HT) and the rabbit isolated pulmonary artery (RPA) bioassays increases with Xaa lipophilicity; cyclo(Leu psi[CH2NH]Cha-Gln-Trp-Phe-beta Ala) and cyclo(Leu psi[CH2NH]Asp(NHBzl)-Gln-Trp-Phe-beta Ala) resulted in being the two most active antagonists (pA2 = 9.06 and 9.26 on HT, respectively). A significant linear correlation was found between pA2 values determined in HT and RPA bioassays and capacity factors measured in reversed phase HPLC. The comparison between the biological activities of cyclic hexapeptides containing or not containing the aminomethylene moiety proved the crucial role of the pseudopeptide bond for determining high antagonist potency at the NK-2 receptor.
authors.affiliation: Chemistry Department, A. Menarini Industrie Farmaceutiche Riunite, Firenze, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Quartara
authors.forename: G
authors.initials: G
authors.lastname: Fabbri
authors.forename: R
authors.initials: R
authors.lastname: Ricci
authors.forename: R
authors.initials: R
authors.lastname: Patacchini
authors.forename: V
authors.initials: V
authors.lastname: Pestellini
authors.forename: C A
authors.initials: CA
authors.lastname: Maggi
authors.forename: V
authors.initials: V
authors.lastname: Pavone
authors.forename: A
authors.initials: A
authors.lastname: Giachetti
authors.forename: F
authors.initials: F
authors.lastname: Arcamone
mesh_terms: D000478:Alkylation; D000595:Amino Acid Sequence; D000818:Animals; D001681:Biological Assay; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D003500:Cyclization; D050356:Lipid Metabolism; D008297:Male; D008647:Mesocricetus; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000494:pharmacology; D011651:Pulmonary Artery / Q000378:metabolism; D011817:Rabbits; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D014132:Trachea / Q000378:metabolism
chemical_list: D010455:Peptides; D010456:Peptides, Cyclic; D018041:Receptors, Neurokinin-2; C090052:cyclo(leucyl-psi(methyleneamino)-aspartyl(benzylamino)-glutaminyl-tryptophyl-phenylalanyl-beta-alanine); C084134:MEN 10612